Total Funding
4
1
Total FundingFunding Round raised
Growth Score
0 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
323180
Vision Medicines develops therapies for blinding ocular diseases, focusing on retinal conditions.
Reza Dana: Co-founder- Chris Varma: Founder, Chairman & CEOPast Role: Blueprint Medicines, President and CEO
About the Company
Vision Medicines is a biopharmaceutical company focused on creating innovative therapies for patients with blinding ocular diseases. The company is developing VM100 for age-related macular degeneration and VM200 for Stargardt disease, aiming to address unmet medical needs in retinal diseases.
Women Founded
